Literature DB >> 17068332

Deficiency of the zinc finger protein ZPR1 causes defects in transcription and cell cycle progression.

Laxman Gangwani1.   

Abstract

The zinc finger protein ZPR1 is present in both the cytoplasm and nucleoplasm. Cell cycle analysis demonstrates that ZPR1 undergoes major changes in subcellular distribution during proliferation. ZPR1 is diffusely localized throughout the cell during the G(1) and G(2)/M phases of the cell cycle. In contrast, ZPR1 redistributes to the nucleus during S phase and ZPR1 exhibits prominent co-localization with the survival motor neurons protein and the histone gene-specific transcription factor NPAT in subnuclear foci, including Cajal bodies that associate with histone gene clusters. ZPR1 deficiency causes disruption of survival motor neurons and NPAT localization within the nucleus, blocks S phase progression, and arrests cells in both the G(1) and G(2) phases of the cell cycle. These changes in subnuclear architecture and cell cycle progression may be caused by transcriptional defects in ZPR1-deficient cells, including decreased histone gene expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17068332     DOI: 10.1074/jbc.M608165200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Association of FURIN and ZPR1 polymorphisms with metabolic syndrome.

Authors:  Chikara Ueyama; Hideki Horibe; Yuichiro Yamase; Tetsuo Fujimaki; Mitsutoshi Oguri; Kimihiko Kato; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-06-29

2.  The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy.

Authors:  Saif Ahmad; Yi Wang; Gouse M Shaik; Arthur H Burghes; Laxman Gangwani
Journal:  Hum Mol Genet       Date:  2012-03-14       Impact factor: 6.150

3.  Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer.

Authors:  Rachael V Phillips; Linda Rieswijk; Alan E Hubbard; Roel Vermeulen; Jinming Zhang; Wei Hu; Laiyu Li; Bryan A Bassig; Jason Y Y Wong; Boris Reiss; Yongshun Huang; Cuiju Wen; Mark Purdue; Xiaojiang Tang; Luoping Zhang; Martyn T Smith; Nathaniel Rothman; Qing Lan
Journal:  Epigenetics       Date:  2019-06-26       Impact factor: 4.528

Review 4.  R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy.

Authors:  Juliana Cuartas; Laxman Gangwani
Journal:  Front Cell Neurosci       Date:  2022-06-16       Impact factor: 6.147

5.  Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy.

Authors:  Graham C Parker; Xingli Li; Roumen A Anguelov; Gabor Toth; Adam Cristescu; Gyula Acsadi
Journal:  Neurotox Res       Date:  2008-01       Impact factor: 3.911

6.  Structural insights into the interaction of the evolutionarily conserved ZPR1 domain tandem with eukaryotic EF1A, receptors, and SMN complexes.

Authors:  Ashwini K Mishra; Laxman Gangwani; Roger J Davis; David G Lambright
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-17       Impact factor: 11.205

7.  Drosophila Zpr1 (Zinc finger protein 1) is required downstream of both EGFR and FGFR signaling in tracheal subcellular lumen formation.

Authors:  Oscar E Ruiz; Linda S Nikolova; Mark M Metzstein
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

8.  Zinc finger protein ZPR1: promising survival motor neuron protein-dependent modifier for the rescue of spinal muscular atrophy.

Authors:  Juliana Cuartas; Laxman Gangwani
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

9.  Effects of nickel, chlorpyrifos and their mixture on the Dictyostelium discoideum proteome.

Authors:  Lara Boatti; Elisa Robotti; Emilio Marengo; Aldo Viarengo; Francesco Marsano
Journal:  Int J Mol Sci       Date:  2012-11-23       Impact factor: 5.923

10.  CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23.

Authors:  Evi Michels; Jasmien Hoebeeck; Katleen De Preter; Alexander Schramm; Bénédicte Brichard; Anne De Paepe; Angelika Eggert; Geneviève Laureys; Jo Vandesompele; Frank Speleman
Journal:  BMC Cancer       Date:  2008-06-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.